{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:09:19Z","timestamp":1791857359426,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jconrel.2021.09.025","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:30:05Z","timestamp":1632191405000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Cyclodextrins-modified metallic nanoparticles for effective cancer therapy"],"prefix":"10.1016","volume":"339","author":[{"given":"Sahil","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jconrel.2021.09.025_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0015","doi-asserted-by":"crossref","first-page":"152729","DOI":"10.1016\/j.prp.2019.152729","article-title":"Tumor microenvironment components: allies of cancer progression","volume":"216","author":"Franco","year":"2020","journal-title":"Pathol.-Res. Pract."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","article-title":"Tumor microenvironment: sanctuary of the devil","volume":"368","author":"Hui","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jns.12226","article-title":"Pain in chemotherapy-induced peripheral neurotoxicity","volume":"22","author":"Marmiroli","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"5","key":"10.1016\/j.jconrel.2021.09.025_bb0035","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2015.12.374","article-title":"Long-term bone marrow suppression during postoperative chemotherapy in rectal cancer patients after preoperative chemoradiation therapy","volume":"94","author":"Newman","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.09.025_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2016.01.040","article-title":"Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: in vitro and in vivo evaluation","volume":"500","author":"Alibolandi","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/mmy\/myu070","article-title":"Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice","volume":"53","author":"Olson","year":"2014","journal-title":"Sabouraudia"},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijpharm.2011.11.035","article-title":"Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability","volume":"423","author":"Benival","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/17425247.2016.1142526","article-title":"Recent advances in oral delivery of peptide hormones","volume":"13","author":"Varamini","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.actbio.2015.01.041","article-title":"Optimization of multifunctional chitosan\u2013siRNA nanoparticles for oral delivery applications, targeting TNF-\u03b1 silencing in rats","volume":"17","author":"He","year":"2015","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0065","doi-asserted-by":"crossref","first-page":"085","DOI":"10.4172\/1948-593X.1000049","article-title":"Nobel metallic nanoparticles with novel biomedical properties","volume":"3","author":"Rosarin","year":"2011","journal-title":"J. Bioanal. Biomed."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0070","first-page":"265","article-title":"Nanoencapsulation for drug delivery","volume":"13","author":"Kumari","year":"2014","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nano.2009.07.002","article-title":"Biological synthesis of metallic nanoparticles","volume":"6","author":"Thakkar","year":"2010","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11051-009-9602-5","article-title":"Process variables in biomimetic synthesis of silver nanoparticles by aqueous extract of Azadirachta indica (Neem) leaves","volume":"12","author":"Tripathy","year":"2010","journal-title":"J. Nanopart. Res."},{"issue":"8","key":"10.1016\/j.jconrel.2021.09.025_bb0085","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.arabjc.2014.12.014","article-title":"Synthesis of silver nanoparticles with different shapes","volume":"12","author":"Khodashenas","year":"2019","journal-title":"Arab. J. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2021.09.025_bb0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/1061186X.2017.1400553","article-title":"Recent advances in metal nanoparticles in cancer therapy","volume":"26","author":"Sharma","year":"2018","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0975-7406.72127","article-title":"Introduction to metallic nanoparticles","volume":"2","author":"Mody","year":"2010","journal-title":"J. Pharm. Bioallied Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.09.025_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2013.12.004","article-title":"Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications","volume":"461","author":"Zafar","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2021.09.025_bb0105","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1517\/17425247.2015.1026893","article-title":"Recent advances in cyclodextrin delivery techniques","volume":"12","author":"Arima","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0110","series-title":"Nanomaterials for Clinical Applications","first-page":"29","article-title":"Cyclodextrin-based drug delivery systems","author":"Jug","year":"2020"},{"issue":"9","key":"10.1016\/j.jconrel.2021.09.025_bb0115","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","article-title":"Cyclodextrins and their uses: a review","volume":"39","author":"Del Valle","year":"2004","journal-title":"Process Biochem."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"4\u20135","key":"10.1016\/j.jconrel.2021.09.025_bb0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejps.2008.04.005","article-title":"P-glycoprotein inhibition by membrane cholesterol modulation","volume":"34","author":"Fenyvesi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3565(24)41709-6","article-title":"Contribution of P-glycoprotein to the enhancing effects of dimethyl-\u03b2-cyclodextrin on oral bioavailability of tacrolimus","volume":"297","author":"Arima","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/B:PHAM.0000022409.27896.d4","article-title":"Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-\u03b2-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers","volume":"21","author":"Arima","year":"2004","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2021.09.025_bb0140","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1248\/yakushi.124.909","article-title":"Pharmaceutical application of cyclodextrins as multi-functional drug carriers","volume":"124","author":"Uekama","year":"2004","journal-title":"Yakugaku zasshi: J. Pharm. Soc. Japan"},{"issue":"8","key":"10.1016\/j.jconrel.2021.09.025_bb0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1248\/cpb.52.900","article-title":"Design and evaluation of cyclodextrin-based drug formulation","volume":"52","author":"Uekama","year":"2004","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0150","first-page":"91","article-title":"Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes","author":"Arima","year":"2011","journal-title":"Cyclod. Pharm. Cosm. Biomed."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0160","series-title":"Report Published in Support of the \u2018Questions and Answers on Cyclodextrins used as Excipients in Medicinal Products for Human Use","article-title":"Cyclodextrins used as excipients","author":"EMA, C","year":"2017"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0165","article-title":"Cyclodextrins in parenteral formulations","author":"Loftsson","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2021.09.025_bb0170","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.xphs.2019.01.004","article-title":"Cyclodextrin reduces intravenous toxicity of a model compound","volume":"108","author":"Mantik","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0175","first-page":"123","article-title":"Regulatory status of cyclodextrins in pharmaceutical products","author":"Hincal","year":"2011","journal-title":"Cyclod. Pharm. Cosm. Biomed."},{"issue":"11","key":"10.1016\/j.jconrel.2021.09.025_bb0180","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40005-019-00434-2","article-title":"Solubility enhancement and application of cyclodextrins in local drug delivery","volume":"50","author":"Kim","year":"2020","journal-title":"J. Pharm. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4155\/tde.11.140","article-title":"Molecular buckets: cyclodextrins for oral cancer therapy","volume":"3","author":"Calleja","year":"2012","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.34172\/apb.2020.022","article-title":"Cyclodextrin based nanoparticles for drug delivery and theranostics","volume":"10","author":"Gadade","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.msec.2018.11.031","article-title":"Cyclodextrin-based delivery systems for cancer treatment","volume":"96","author":"Zhang","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0205","series-title":"Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications","first-page":"555","article-title":"Responsive cyclodextrins as polymeric carriers for drug delivery applications","volume":"Vol. 1","author":"Parmar","year":"2018"},{"issue":"5","key":"10.1016\/j.jconrel.2021.09.025_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.21452","article-title":"Cyclodextrin complexes: perspective from drug delivery and formulation","volume":"79","author":"Jacob","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0215","doi-asserted-by":"crossref","first-page":"115805","DOI":"10.1016\/j.carbpol.2019.115805","article-title":"Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: a review","volume":"232","author":"Tian","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.jconrel.2021.09.025_bb0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijpharm.2017.06.080","article-title":"Cyclodextrin-modified inorganic materials for the construction of nanocarriers","volume":"531","author":"Cutrone","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0225","first-page":"37","article-title":"Surfactant-assisted ball milling: a novel route to novel materials with controlled nanostructure-a review","author":"Ullah","year":"2014","journal-title":"Rev. Adv. Mater. Sci."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0230","first-page":"237","article-title":"Nanosization of drug biomaterials and its solubility enhancement by high energy ball milling","author":"Thamizharasan","year":"2017","journal-title":"J. Nanosci. Technol."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0235","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00339-004-2660-8","article-title":"Nanoparticles produced by laser ablation of solids in liquid environment","volume":"79","author":"Simakin","year":"2004","journal-title":"Appl. Phys. A"},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.arabjc.2010.04.008","article-title":"Synthesis and applications of silver nanoparticles","volume":"3","author":"Abou El-Nour","year":"2010","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0245","series-title":"Gold Nanoparticles in Ionic Liquids Prepared by Sputter Deposition","author":"Vanecht","year":"2012"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0250","doi-asserted-by":"crossref","first-page":"116401","DOI":"10.1016\/j.carbpol.2020.116401","article-title":"Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems","volume":"242","author":"Tian","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0255","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acs.molpharmaceut.9b00144","article-title":"Cyclodextrin polymer preserves sirolimus activity and local persistence for antifibrotic delivery over the time course of wound healing","volume":"16","author":"Rohner","year":"2019","journal-title":"Mol. Pharm."},{"issue":"34","key":"10.1016\/j.jconrel.2021.09.025_bb0260","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1039\/C7RA02306E","article-title":"Template-directed synthesis of a cubic cyclodextrin polymer with aligned channels and enhanced drug payload","volume":"7","author":"Singh","year":"2017","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10311-018-0779-7","article-title":"Synthesis of substituted cyclodextrins","volume":"17","author":"\u0158ezanka","year":"2019","journal-title":"Environ. Chem. Lett."},{"issue":"5","key":"10.1016\/j.jconrel.2021.09.025_bb0270","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1021\/cr970012b","article-title":"Methods for selective modifications of cyclodextrins","volume":"98","author":"Khan","year":"1998","journal-title":"Chem. Rev."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.09.025_bb0275","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"24","key":"10.1016\/j.jconrel.2021.09.025_bb0280","doi-asserted-by":"crossref","first-page":"20348","DOI":"10.1021\/acsami.7b02303","article-title":"Ligand-mediated and enzyme-directed precise targeting and retention for the enhanced treatment of glioblastoma","volume":"9","author":"Ruan","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"36","key":"10.1016\/j.jconrel.2021.09.025_bb0285","doi-asserted-by":"crossref","first-page":"1702311","DOI":"10.1002\/adma.201702311","article-title":"Engineering the surface of smart nanocarriers using a pH\u2212\/thermal-\/GSH-responsive polymer zipper for precise tumor targeting therapy in vivo","volume":"29","author":"Zhang","year":"2017","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0290","first-page":"1","article-title":"Upconversion nanocomposite for programming combination cancer therapy by precise control of microscopic temperature","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0295","doi-asserted-by":"crossref","first-page":"112099","DOI":"10.1016\/j.msec.2021.112099","article-title":"Strategic conceptualization and potential of self-healing polymers in biomedical field","volume":"125","author":"Pathan","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0300","first-page":"116871","article-title":"Smart stimuli-responsive drug delivery systems based on cyclodextrin: a review","author":"Tian","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0305","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.addr.2009.11.007","article-title":"Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer","volume":"62","author":"Patra","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"28","key":"10.1016\/j.jconrel.2021.09.025_bb0310","doi-asserted-by":"crossref","first-page":"15177","DOI":"10.1021\/acsami.5b00186","article-title":"Gold nanoparticles interacting with \u03b2-cyclodextrin\u2013phenylethylamine inclusion complex: a ternary system for photothermal drug release","volume":"7","author":"Sierpe","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.jconrel.2021.09.025_bb0315","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1039\/C4RA13135E","article-title":"A dual targeting cyclodextrin\/gold nanoparticle conjugate as a scaffold for solubilization and delivery of paclitaxel","volume":"5","author":"Chen","year":"2015","journal-title":"RSC Adv."},{"issue":"49","key":"10.1016\/j.jconrel.2021.09.025_bb0320","doi-asserted-by":"crossref","first-page":"495103","DOI":"10.1088\/0957-4484\/24\/49\/495103","article-title":"Vesicular gold assemblies based on host\u2013guest inclusion and its controllable release of doxorubicin","volume":"24","author":"Ha","year":"2013","journal-title":"Nanotechnology"},{"issue":"4","key":"10.1016\/j.jconrel.2021.09.025_bb0325","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/smll.201502913","article-title":"Cooperative treatment of metastatic breast cancer using host\u2013guest nanoplatform coloaded with docetaxel and siRNA","volume":"12","author":"Wang","year":"2016","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.jconrel.2021.09.025_bb0330","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/nano8120985","article-title":"Photothermally controlled methotrexate release system using \u03b2-cyclodextrin and gold nanoparticles","volume":"8","author":"Silva","year":"2018","journal-title":"Nanomaterials"},{"issue":"9\u201310","key":"10.1016\/j.jconrel.2021.09.025_bb0335","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00604-014-1192-y","article-title":"Magnetic nanoparticles grafted with \u03b2-cyclodextrin for solid-phase extraction of 5-hydroxy-3-indole acetic acid","volume":"181","author":"Ahmed","year":"2014","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0340","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.apsusc.2015.09.078","article-title":"Magnetite nanoparticles coated with \u03b2-cyclodextrin functionalized-ionic liquid: synthesis and its preliminary investigation as a new sensing material","volume":"357","author":"Sinniah","year":"2015","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2021.02.044","article-title":"Carbohydrate-based magnetic nanocomposites for effective cancer treatment","author":"Shende","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.jconrel.2021.09.025_bb0350","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.xphs.2018.03.021","article-title":"Role of cyclodextrins in nanoparticle-based drug delivery systems","volume":"107","author":"Shelley","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0355","doi-asserted-by":"crossref","first-page":"110597","DOI":"10.1016\/j.msec.2019.110597","article-title":"A pH-responsive citric-acid\/\u03b1-cyclodextrin-functionalized Fe3O4 nanoparticles as a nanocarrier for quercetin: an experimental and DFT study","volume":"109","author":"Ghafelehbashi","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0360","doi-asserted-by":"crossref","first-page":"101741","DOI":"10.1016\/j.jddst.2020.101741","article-title":"Hyperbranched polyglycerol \u03b2-cyclodextrin as magnetic platform for optimization of doxorubicin cytotoxic effects on Saos-2 bone cancerous cell line","volume":"57","author":"Khelghati","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0365","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.apsusc.2015.09.189","article-title":"Targeted delivery and pH-responsive release of stereoisomeric anti-cancer drugs using \u03b2-cyclodextrin assemblied Fe3O4 nanoparticles","volume":"357","author":"Wang","year":"2015","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2016.03.015","article-title":"Formation and characterization of \u03b2-cyclodextrin (\u03b2-CD)\u2013polyethyleneglycol (PEG)\u2013polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-fluorouracil drug","volume":"80","author":"Prabha","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0375","first-page":"4679","article-title":"Nanotheranostics\u2013a review of recent publications","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0380","article-title":"Current strategies of radiopharmaceuticals in theranostic applications","volume":"102594","author":"Shende","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/nano.202000141","article-title":"Nanotheranostics in epilepsy: a perspective for multimodal diagnosis and strategic management","author":"Shende","year":"2021","journal-title":"Nano Select."},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0390","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.biomaterials.2011.09.064","article-title":"Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy","volume":"33","author":"Heo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.09.025_bb0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actbio.2016.02.020","article-title":"Hierarchical self-assembly of magnetic nanoclusters for theranostics: tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery","volume":"35","author":"Nguyen","year":"2016","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0400","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/nano8030170","article-title":"Cyclodextrin-based magnetic nanoparticles for cancer therapy","volume":"8","author":"Mr\u00f3wczy\u0144ski","year":"2018","journal-title":"Nanomaterials"},{"issue":"12","key":"10.1016\/j.jconrel.2021.09.025_bb0405","doi-asserted-by":"crossref","first-page":"47250","DOI":"10.1002\/app.47250","article-title":"Gold nanoparticle conjugated poly (p-phenylene-\u03b2-cyclodextrin) -graft-poly (ethylene glycol) for theranostic applications","volume":"136","author":"Barlas","year":"2019","journal-title":"J. Appl. Polym. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2021.09.025_bb0410","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1871520614666141202144152","article-title":"Gold nanoparticle-lignan complexes inhibited MCF-7 cell proliferation in vitro: a novel conjugation for cancer therapy","volume":"15","author":"Bakar","year":"2015","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.jconrel.2021.09.025_bb0415","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.bmcl.2016.03.097","article-title":"Delivery of tanshinone IIA and \u03b1-mangostin from gold\/PEI\/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy","volume":"26","author":"Qiu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.jconrel.2021.09.025_bb0420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bmcl.2019.03.003","article-title":"Enhanced cytotoxicity of gold porphyrin complexes after inclusion in cyclodextrin scaffolds adsorbed on polyethyleneimine-coated gold nanoparticles","volume":"29","author":"Granet","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.jconrel.2021.09.025_bb0425","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1039\/b816209c","article-title":"Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug","volume":"19","author":"Park","year":"2009","journal-title":"J. Mater. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2021.09.025_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1744-7402.2008.02332.x","article-title":"Grafting of 2-Hydroxypropyl-\u03b2-Cyclodextrin on gum Arabic-modified Iron oxide nanoparticles as a magnetic carrier for targeted delivery of hydrophobic anticancer drug","volume":"7","author":"Banerjee","year":"2010","journal-title":"Int. J. Appl. Ceram. Technol."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2016.11.091","article-title":"Magnetic nanoparticles coated with cyclodextrins and citrate for irinotecan delivery","volume":"163","author":"Monteiro","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0440","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.matchemphys.2018.07.022","article-title":"\u03b2-Cyclodextrin grafted magnetic graphene oxide applicable as cancer drug delivery agent: synthesis and characterization","volume":"218","author":"Pooresmaeil","year":"2018","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.jconrel.2021.09.025_bb0445","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.msec.2019.01.068","article-title":"Development of gold-core silica shell nanospheres coated with poly-2-ethyl-oxazoline and \u03b2-cyclodextrin aimed for cancer therapy","volume":"98","author":"Reis","year":"2019","journal-title":"Mater. Sci. Eng. C"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921005046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:21:53Z","timestamp":1778300513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921005046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":88,"alternative-id":["S0168365921005046"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclodextrins-modified metallic nanoparticles for effective cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}